1. Home
  2. Standardized Extracts
  3. Corydalis Extract
Standardized ExtractPharmaceutical activeTraditional Chinese Medicine

Corydalis Extract (Corydalis yanhusuo) – Tetrahydropalmatine 1–98%

Corydalis yanhusuo · Papaveraceae

Regulated ingredient — check your market before you buy

Pharmaceutical active / prescription-only in many markets

Orders are released after a compliance review of the intended use and destination market.

Marker compound
Tetrahydropalmatine
Standardisation
1–98% (HPLC)
Assay method
HPLC
CAS
10097-84-4
Plant part
Tuber & Bulb
Origin
China

Corydalis Extract (Corydalis yanhusuo) – Tetrahydropalmatine 1–98%

Corydalis extract is produced from the tuber of Corydalis yanhusuo (Papaveraceae family) and supplied as a standardized extract powder, standardized to Tetrahydropalmatine. Available grades: 1%, 5%, 20%, 98%. Typical sourcing: China. For B2B formulation in pharmaceutical.

1%5%20%98%

Specifications

Botanical name Corydalis yanhusuo
Common names Corydalis
Plant family / part Papaveraceae / Tuber
Marker compound Tetrahydropalmatine
Phytochemical class Alkaloids › Isoquinoline alkaloids
Available grades 1%, 5%, 20%, 98%
Made-to-order grades 5%, 20% (produced on request; confirm lead time)
Assay method HPLC
CAS number 10097-84-4
Pharmacopoeia & standards Chinese Pharmacopoeia
Form Standardized Extract
Origin China
Pack sizes Sample (50 g), 250 g, 1 Kg, 5 Kg, 25 Kg; 98% grade: Sample (1 g), 50 g, 250 g, 1 Kg
Shelf life & storage Typically 24 months in sealed original packaging; store cool, dry and away from light

Regulatory status

  • Pharmaceutical active / prescription-only in many markets

Supplied only to qualified business buyers for lawful manufacturing, research or pharmaceutical use. Buyers are responsible for compliance in their market.

Industries

Pharmaceutical

Documentation

The Technical Data Sheet and Safety Data Sheet (GHS format) can be downloaded from this page; the batch Certificate of Analysis is supplied on request. Confirm the assay method (HPLC, UV or gravimetric) on the CoA, as results differ between methods.

For B2B formulation and research use. Statements have not been evaluated by the FDA or other regulators; this ingredient is not intended to diagnose, treat, cure or prevent any disease.